AzTrials
AzTrials

Diabetes MellitusNCT00842010

Characteristics of Non Diabetic Hyperglycemic Inpatients

An observational study of Diabetes Mellitus, run by Cook County Health at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Retrospective nested non-matched case control study comparing patients by glycemic status Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Diabetes Mellitus
How many people
600 participants
Where
1 siteUnited States
Study dates
Mar 2006to Dec 2008
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Nested sample obtained from patients admitted to John H. Stroger Jr. Hospital from March-April 2006 and in October 2007.

Who may be able to join

  • Admitted to John H. Stroger Jr. Hospital
  • Admitted to Internal Medicine Service from March-April 2006 and in October 2007

Who cannot join

  • Transfer from any intensive care unit (medical or surgical)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • John H. Stroger Jr. Hospital

    Chicago, Illinois, 60612

Other trials in United States

About this study

Official title: Hyperglycemic Non Diabetic (HND) Hospital Patients: Are They Different From Diabetic Hyperglycemic and Non-Hyperglycemic Non-Diabetic(NHND) Patients?

Retrospective nested non-matched case control study comparing patients by glycemic status

Read the detailed description

This retrospective nested non-matched case control study compared patients directly admitted to the General Medicine Wards, not transferred from ICU with

  • hyperglycemia on admission but no previous diagnosis of diabetes
  • diabetic hyperglycemic patients
  • non hyperglycemic non diabetic patients from the same nested population.

The investigators' hypothesis is that the clinical characteristics and endpoints of the non diabetic hyperglycemics should be similar to the diabetic population and different from the non diabetic non hyperglycemic population.

Keywords
Diabetes, Inpatient, Hospital, Hyperglycemia
Medical subject headings
Diabetes Mellitus, Hyperglycemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00842010
Study groupRoleWhat they receive
Hyperglycemic without previous DM diagnosisPatients with hyperglycemia, without previous diagnosis of diabetes
Previous diagnosis of DMPatients that have previous diagnosis of Diabetes Mellitus
No previous DM diagnosis and no hyperglycemiaPatient with NO previous diagnosis of diabetes, and no hyperglycemia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Length of stay

    Hospital stay measured in days

    Measured: Measured 24 hours after patient is discharged. From day 1 of admission until day of discharge

  2. Inpatient Mortality

    Mortality measured in number of events

    Measured: From day 1 of admission until day of discharge

Secondary outcomes (4)
  1. Frequency of SIRS on admission

    Number of SIRS

    Measured: Measures obtained 24 hours after patient is discharged. Clinical data obtained on day 1 of admission

  2. Frequency of inpatient infection

    Measured in number of events

    Measured: From day 1 of admission until day of discharge

  3. Rate of use of intravenous glucose drip

    Rate of use

    Measured: From day 1 of admission until day of discharge

  4. Frequency of steroid use

    Frequency of use

    Measured: From day 1 of admission until day of discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Feb 2009 (estimated)
  2. Study startMar 2006
  3. Primary completionDec 2007
  4. Study completionDec 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
600 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00842010
Sponsor's protocol ID
06-063
Status last verified
Sep 2023
First submitted
11 Feb 2009
Last updated
28 Sep 2023
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Diabetes Mellitus, run by Cook County Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Length of stay (time frame: Measured 24 hours after patient is discharged. From day 1 of admission until day of discharge). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2023; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in